Literature DB >> 9399938

Pathways and mechanisms for cytokine signaling of the central nervous system.

J Licinio1, M L Wong.   

Abstract

Mesh：

Substances：

Year:  1997        PMID： 9399938      PMCID： PMC508504          DOI： 10.1172/JCI119846

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  30 in total

1.  Release of multiple hormones by a direct action of interleukin-1 on pituitary cells.

Authors:  E W Bernton; J E Beach; J W Holaday; R C Smallridge; H G Fein
Journal:  Science       Date:  1987-10-23       Impact factor: 47.728

2.  Interleukin-1 alpha as a factor in occlusive vascular disease.

Authors:  J I Brody; N J Pickering; D M Capuzzi; G B Fink; C A Can; F Gomez
Journal:  Am J Clin Pathol       Date:  1992-01       Impact factor: 2.493

Review 3.  The neurologic basis of fever.

Authors:  C B Saper; C D Breder
Journal:  N Engl J Med       Date:  1994-06-30       Impact factor: 91.245

4.  Endogenous interleukin-1 receptor antagonist is neuroprotective.

Authors:  S A Loddick; M L Wong; P B Bongiorno; P W Gold; J Licinio; N J Rothwell
Journal:  Biochem Biophys Res Commun       Date:  1997-05-08       Impact factor: 3.575

5.  Elevated CSF levels of interleukin-2 in neuroleptic-free schizophrenic patients.

Authors:  J Licinio; J P Seibyl; M Altemus; D S Charney; J H Krystal
Journal:  Am J Psychiatry       Date:  1993-09       Impact factor: 18.112

6.  Human interleukin (IL) 1 alpha, murine IL-1 alpha and murine IL-1 beta are transported from blood to brain in the mouse by a shared saturable mechanism.

Authors:  W A Banks; L Ortiz; S R Plotkin; A J Kastin
Journal:  J Pharmacol Exp Ther       Date:  1991-12       Impact factor: 4.030

7.  Inhibitory effect of recombinant intracellular interleukin 1 receptor antagonist on endothelial cell activation.

Authors:  R Bertini; M Sironi; I Martin-Padura; F Colotta; S Rambaldi; S Bernasconi; P Ghezzi; S J Haskill; D Liu; A Mantovani
Journal:  Cytokine       Date:  1992-01       Impact factor: 3.861

8.  Endotoxin-induced corticotropin-releasing hormone gene expression in the hypothalamic paraventricular nucleus is mediated centrally by interleukin-1.

Authors:  I Kakucska; Y Qi; B D Clark; R M Lechan
Journal:  Endocrinology       Date:  1993-08       Impact factor: 4.736

9.  Distribution and characterization of tumor necrosis factor-alpha-like immunoreactivity in the murine central nervous system.

Authors:  C D Breder; M Tsujimoto; Y Terano; D W Scott; C B Saper
Journal:  J Comp Neurol       Date:  1993-11-22       Impact factor: 3.215

10.  Localization of interleukin-1 receptor antagonist mRNA in rat brain.

Authors:  J Licinio; M L Wong; P W Gold
Journal:  Endocrinology       Date:  1991-07       Impact factor: 4.736
View more
  42 in total

1.  The association of genetic variants in interleukin-1 genes with cognition: findings from the cardiovascular health study.

Authors:  K S Benke; M C Carlson; B Q Doan; J D Walston; Q L Xue; A P Reiner; L P Fried; D E Arking; A Chakravarti; M D Fallin
Journal:  Exp Gerontol       Date:  2011-09-24       Impact factor: 4.032

Review 2.  Changing face of hepatic encephalopathy: role of inflammation and oxidative stress.

Authors:  Amit S Seyan; Robin D Hughes; Debbie L Shawcross
Journal:  World J Gastroenterol       Date:  2010-07-21       Impact factor: 5.742

Review 3.  Blockade of brain angiotensin II AT1 receptors ameliorates stress, anxiety, brain inflammation and ischemia: Therapeutic implications.

Authors:  Juan M Saavedra; Enrique Sánchez-Lemus; Julius Benicky
Journal:  Psychoneuroendocrinology       Date:  2010-10-29       Impact factor: 4.905

Review 4.  Inflammation: A novel target of current therapies for hepatic encephalopathy in liver cirrhosis.

Authors:  Ming Luo; Jian-Yang Guo; Wu-Kui Cao
Journal:  World J Gastroenterol       Date:  2015-11-07       Impact factor: 5.742

Review 5.  Role of microglia in central nervous system infections.

Authors:  R Bryan Rock; Genya Gekker; Shuxian Hu; Wen S Sheng; Maxim Cheeran; James R Lokensgard; Phillip K Peterson
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

6.  Role of ammonia and inflammation in minimal hepatic encephalopathy.

Authors:  D L Shawcross; G Wright; S W M Olde Damink; R Jalan
Journal:  Metab Brain Dis       Date:  2007-03       Impact factor: 3.584

7.  Increased levels of interleukins 2 and 17 in the cerebrospinal fluid of patients with idiopathic intracranial hypertension.

Authors:  Laura J Edwards; Basil Sharrack; Azza Ismail; Christopher R Tench; Bruno Gran; Samish Dhungana; Johannes Brettschneider; Hayrettin Tumani; Cris S Constantinescu
Journal:  Am J Clin Exp Immunol       Date:  2013-10-16

Review 8.  Angiotensin II AT(1) receptor blockers as treatments for inflammatory brain disorders.

Authors:  Juan M Saavedra
Journal:  Clin Sci (Lond)       Date:  2012-11       Impact factor: 6.124

9.  N-acetylcysteine attenuates cerebral complications of non-acetaminophen-induced acute liver failure in mice: antioxidant and anti-inflammatory mechanisms.

Authors:  Chantal Bémeur; Javier Vaquero; Paul Desjardins; Roger F Butterworth
Journal:  Metab Brain Dis       Date:  2010-04-30       Impact factor: 3.584

10.  Mangiferin decreases inflammation and oxidative damage in rat brain after stress.

Authors:  Lucía Márquez; Borja García-Bueno; José L M Madrigal; Juan C Leza
Journal:  Eur J Nutr       Date:  2011-10-07       Impact factor: 5.614
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.